...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats
【24h】

Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats

机译:阿托伐他汀联合缺血后处理对糖尿病和非糖尿病大鼠心脏保护作用的比较

获取原文
获取原文并翻译 | 示例

摘要

The aim of the present study was to investigate whether the combination of acute or chronic atorvastatin treatment with ischaemic post-conditioning (IPost) exerts differential effects within the hearts of diabetic and non-diabetic rats. Diabetic and non-diabetic rats were randomly assigned to one of six groups: (i) a non-conditioned group; (ii) a group subjected to IPost; (iii) acute statin treatment (50 μmol/L atorvastatin during reperfusion) without IPost; (iv) acute statin treatment plus IPost; (v) chronic statin treatment (10 mg/kg atorvastatin per day for 2 weeks) without IPost; and (vi) chronic statin treatment plus IPost. The hearts from rats in each group were subjected to 30 min global ischaemia, followed by 120 min reperfusion. Infarct size, haemodynamics and Akt and endothelial nitric oxide synthase (eNOS) expression were examined. In hearts from diabetic rats, IPost did not limit infarct size or recover contractile dysfunction. Acute atorvastatin treatment with IPost limited infarct size and recovered contractile dysfunction in hearts from both diabetic and non-diabetic rats and further activated Akt and eNOS signalling pathways to enhance these protective effects in hearts from diabetic rats. Chronic statin treatment with IPost neither reduced infarct size nor increased recovery of myocardial dysfunction in hearts from both diabetic and non-diabetic rats; this may be associated with inhibition of Akt and eNOS phosphorylation. The combination of acute atorvastatin treatment with IPost had a greater protective effect within hearts from diabetic rats, but chronic statin treatment with IPost failed to protect against reperfusion injury in hearts from either diabetic or non-diabetic rats. These findings will be important for the design of future clinical investigations.
机译:本研究的目的是研究急性或慢性阿托伐他汀与缺血性后处理(IPost)的组合在糖尿病和非糖尿病大鼠心脏中是否发挥不同的作用。将糖尿病和非糖尿病大鼠随机分为六组之一:(i)非条件组; (ii)受IPost约束的团体; (iii)不使用IPost的急性他汀类药物治疗(再灌注期间50μmol/ L阿托伐他汀); (iv)急性他汀类药物治疗加IPost; (v)不使用IPost的慢性他汀类药物治疗(每天10 mg / kg阿托伐他汀,持续2周); (vi)慢性他汀类药物治疗加IPost。每组大鼠的心脏均接受30分钟的全脑缺血,然后再灌注120分钟。检查梗死面积,血流动力学,Akt和内皮型一氧化氮合酶(eNOS)的表达。在糖尿病大鼠的心脏中,IPost并没有限制梗塞面积或恢复收缩功能障碍。用IPost进行的急性阿托伐他汀治疗可限制梗死面积,并能恢复糖尿病和非糖尿病大鼠心脏的收缩功能障碍,并进一步激活Akt和eNOS信号通路来增强糖尿病大鼠心脏的这些保护作用。用IPost进行慢性他汀类药物的治疗,既不会减少糖尿病大鼠和非糖尿病大鼠的心肌梗塞面积,也不会增加其心肌功能障碍的恢复;这可能与抑制Akt和eNOS磷酸化有关。急性阿托伐他汀联合IPost的治疗对糖尿病大鼠的心脏具有更大的保护作用,但慢性statin与IPost的联合治疗无法预防糖尿病或非糖尿病大鼠心脏的再灌注损伤。这些发现对于未来临床研究的设计将是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号